Index of reports
> Cases with Hyponatraemia (5)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Inspra (Eplerenone) where reactions include hyponatraemia. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Inspra side effects in 70 year old female
Reported by a consumer/non-health professional from Germany on 2012-02-07
Patient: 70 year old female
Reactions: Renal Failure, Hyperkalaemia, Sepsis, Hyponatraemia, Epistaxis, Lividity, Erysipelas
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Inspra
Dosage: 50 mg, 1x/day
Administration route: Oral
Indication: Cardiac Failure
Start date: 2009-04-01
End date: 2009-06-17
Altace
Dosage: 1.25 mg, 1x/day
Administration route: Oral
Indication: Cardiac Failure
End date: 2009-06-17
Other drugs received by patient: Berlthyrox; Torsemide; Falithrom; Simvastatin
Possible Inspra side effects in 70 year old female
Reported by a physician from Germany on 2012-01-26
Patient: 70 year old female
Reactions: Renal Failure, Hyperkalaemia, Sepsis, Hyponatraemia, Lividity, Erysipelas, Epistaxis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Ramipril
Dosage: 1.25 mg, 1x/day
Administration route: Oral
Indication: Cardiac Failure
End date: 2009-06-17
Inspra
Dosage: 50 mg, 1x/day
Administration route: Oral
Indication: Cardiac Failure
Start date: 2009-04-01
End date: 2009-06-17
Other drugs received by patient: Falithrom; Falithrom; Berlthyrox; Torsemide; Simvastatin
Possible Inspra side effects in 70 year old female
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-01-26
Patient: 70 year old female
Reactions: Renal Failure, Hyperkalaemia, Sepsis, Hyponatraemia, Epistaxis, Erysipelas, Lividity
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Altace
Dosage: 1.25 mg, 1x/day
Administration route: Oral
Indication: Cardiac Failure
End date: 2009-06-17
Inspra
Dosage: 50 mg, 1x/day
Administration route: Oral
Indication: Cardiac Failure
Start date: 2009-04-01
End date: 2009-06-17
Other drugs received by patient: Torsemide; Berlthyrox; Simvastatin; Falithrom
Possible Inspra side effects in male
Reported by a health professional (non-physician/pharmacist) from Canada on 2011-11-21
Patient: male
Reactions: Hyponatraemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Inspra
Possible Inspra side effects in
Reported by a health professional (non-physician/pharmacist) from Canada on 2011-11-16
Patient:
Reactions: Hyponatraemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Inspra
|